- Drug Pipelines
- September 2024
- 247 Pages
Global
From €7547EUR$7,950USD£6,366GBP
- Drug Pipelines
- April 2024
- 80 Pages
Global
From €1899EUR$2,000USD£1,602GBP
- Report
- April 2024
- 30 Pages
Global
From €2611EUR$2,750USD£2,202GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1899EUR$2,000USD£1,602GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1424EUR$1,500USD£1,201GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1187EUR$1,250USD£1,001GBP
- Report
- January 2025
- 250 Pages
Global
From €4746EUR$4,999USD£4,003GBP
- Report
- January 2025
- 250 Pages
Global
From €4746EUR$4,999USD£4,003GBP
- Report
- February 2025
- 180 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- June 2024
- 181 Pages
Global
From €4742EUR$4,995USD£4,000GBP
- Report
- February 2025
- 100 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- August 2023
- 147 Pages
Global
From €7120EUR$7,500USD£6,006GBP
- Report
- October 2022
- 120 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1424EUR$1,500USD£1,201GBP
- Report
- August 2023
- 201 Pages
Global
From €7120EUR$7,500USD£6,006GBP
- Report
- February 2023
- 120 Pages
Global
From €7120EUR$7,500USD£6,006GBP
- Report
- February 2024
- 180 Pages
Global
From €4717EUR$4,969USD£3,979GBP
- Report
- April 2023
- 160 Pages
Global
From €4698EUR$4,949USD£3,963GBP
- Report
- March 2023
- 117 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- October 2022
- 113 Pages
Global
From €4509EUR$4,750USD£3,804GBP

Somatostatin is a peptide hormone that is used in the treatment of various types of cancer. It is used to inhibit the release of growth hormones, which can help reduce the size of tumors. It is also used to reduce the side effects of chemotherapy and radiation therapy. Somatostatin is available in both injectable and oral forms. It is often used in combination with other drugs to treat cancer.
Somatostatin is used to treat a variety of cancers, including pancreatic, prostate, and neuroendocrine tumors. It is also used to treat acromegaly, a condition caused by excessive growth hormone production. Somatostatin is also used to treat Cushing's syndrome, a condition caused by excessive cortisol production.
Some companies that produce somatostatin include Novartis, Merck, and Pfizer. Other companies that produce somatostatin-based drugs include Ipsen, Teva, and Sandoz. Show Less Read more